Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Tsironis

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|July 14, 2007
New insights into the role of lipoprotein(a)-associated lipoprotein-associated phospholipase A2 in atherosclerosis and cardiovascular diseaseSotirios Tsimikas, Loukas D Tsironis, Alexandros D Tselepis
Annals of the Royal College of Surgeons of England|August 13, 2015
A diaphragmatic retroperitoneal cystF P Robertson, D Tsironis, B R Davidson
Annals of the Royal College of Surgeons of England|October 16, 2023
Long-term efficacy of total versus posterior partial fundoplication in patients with gastro-oesophageal reflux disease: a systematic review and meta-analysisD V Peristeri, H Room, D Tsironis, et al.
Cardiovascular Research|June 15, 2004
Effect of lipoprotein (a) on platelet activation induced by platelet-activating factor: role of apolipoprotein (a) and endogenous PAF-acetylhydrolaseLoukas D Tsironis, John V Mitsios, Haralampos J Milionis, et al.
Atherosclerosis|December 5, 2006
Short- and long-term elevation of autoantibody titers against oxidized LDL in patients with acute coronary syndromes. Role of the lipoprotein-associated phospholipase A2 and the effect of atorvastatin treatmentAthanasios I Papathanasiou, Evangelia S Lourida, Loukas D Tsironis, et al.
Future Cardiology|October 7, 2009
Lipoprotein(a) as a cardiovascular risk factorChristos S Katsouras, Loukas D Tsironis, Moses Elisaf, et al.
Thyroid : Official Journal of the American Thyroid Association|June 14, 2003
Lipoprotein (a) levels and apolipoprotein (a) isoform size in patients with subclinical hypothyroidism: effect of treatment with levothyroxineHaralampos J Milionis, Zoe Efstathiadou, Alexandros D Tselepis, et al.
Atherosclerosis|October 19, 2004
Reduced PAF-acetylhydrolase activity associated with Lp(a) in patients with coronary artery diseaseLoukas D Tsironis, Christos S Katsouras, Evangelia S Lourida, et al.
New Biotechnology|October 13, 2009
Efficient enzymatic preparation of hydroxycinnamates in ionic liquids enhances their antioxidant effect on lipoproteins oxidative modificationMaria H Katsoura, Angeliki C Polydera, Loukas D Tsironis, et al.
Journal of Lipid Research|August 5, 2006
Autoantibody titers against OxLDL are correlated with Achilles tendon thickness in patients with familial hypercholesterolemiaSofia G Tsouli, Dimitrios N Kiortsis, Evangelia S Lourida, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Arteriosclerosis, Thrombosis, and Vascular Biology|July 14, 2007
New insights into the role of lipoprotein(a)-associated lipoprotein-associated phospholipase A2 in atherosclerosis and cardiovascular diseaseSotirios Tsimikas, Loukas D Tsironis, Alexandros D Tselepis
Annals of the Royal College of Surgeons of England|August 13, 2015
A diaphragmatic retroperitoneal cystF P Robertson, D Tsironis, B R Davidson
Annals of the Royal College of Surgeons of England|October 16, 2023
Long-term efficacy of total versus posterior partial fundoplication in patients with gastro-oesophageal reflux disease: a systematic review and meta-analysisD V Peristeri, H Room, D Tsironis, et al.
Cardiovascular Research|June 15, 2004
Effect of lipoprotein (a) on platelet activation induced by platelet-activating factor: role of apolipoprotein (a) and endogenous PAF-acetylhydrolaseLoukas D Tsironis, John V Mitsios, Haralampos J Milionis, et al.
Atherosclerosis|December 5, 2006
Short- and long-term elevation of autoantibody titers against oxidized LDL in patients with acute coronary syndromes. Role of the lipoprotein-associated phospholipase A2 and the effect of atorvastatin treatmentAthanasios I Papathanasiou, Evangelia S Lourida, Loukas D Tsironis, et al.
Future Cardiology|October 7, 2009
Lipoprotein(a) as a cardiovascular risk factorChristos S Katsouras, Loukas D Tsironis, Moses Elisaf, et al.
Thyroid : Official Journal of the American Thyroid Association|June 14, 2003
Lipoprotein (a) levels and apolipoprotein (a) isoform size in patients with subclinical hypothyroidism: effect of treatment with levothyroxineHaralampos J Milionis, Zoe Efstathiadou, Alexandros D Tselepis, et al.
Atherosclerosis|October 19, 2004
Reduced PAF-acetylhydrolase activity associated with Lp(a) in patients with coronary artery diseaseLoukas D Tsironis, Christos S Katsouras, Evangelia S Lourida, et al.
New Biotechnology|October 13, 2009
Efficient enzymatic preparation of hydroxycinnamates in ionic liquids enhances their antioxidant effect on lipoproteins oxidative modificationMaria H Katsoura, Angeliki C Polydera, Loukas D Tsironis, et al.
Journal of Lipid Research|August 5, 2006
Autoantibody titers against OxLDL are correlated with Achilles tendon thickness in patients with familial hypercholesterolemiaSofia G Tsouli, Dimitrios N Kiortsis, Evangelia S Lourida, et al.
Pageof 2